Major Award For ArjoHuntleigh & Canadian Patients

Share Article

ArjoHuntleigh announces that it has been awarded a major contract for its DVT technology with Medbuy, one of Canada's largest Group purchasing Organizations.

ArjoHuntleigh Canada: ArjoHuntleigh announces that it has been awarded a major contract for its DVT technology with Medbuy, one of Canada's largest Group Purchasing Organizations.

Deep Vein Thrombosis (DVT) is a blood clot usually in the veins of the leg which can be life threatening. Mechanical prophylaxis offered by ArjoHuntleigh is one of the means of preventing unneccessary DVT from occuring. The five year contract will allow ArjoHuntleigh to promote its Flowtron system amongst Medbuy's 25 Members which comprise of approximately 300 acute care hospitals.

John Thiessen, General Manager of ArjoHuntleigh in Canada commented; "We have worked very hard with Medbuy Members for many months and we are all very pleased to have been awarded this important contract for our DVT business in Canada. The Canadian Patient Safety Institute established ten targeted interventions under their Safer Healthcare Now campaign and venous thromboembolism is one of these. Deep Vein Thrombosis may be the leading cause of preventable hospital deaths in North America and the timing of Medbuy's contract award is very significant and good news for patients in Canada."

Bekhe Purkis, Contracting Director at Medbuy said; "Our Members are excited to be working with ArjoHuntleigh and have been impressed with their technology from a clinical and cost perspective. Through this contract, our members will be able to realize substantial cost savings, while achieving their clinical outcomes through mechanical prophylaxis of DVT for patients across Canada."

ArjoHuntleigh offers integrated solutions for the care of patients and residents with reduced mobility and related conditions in virtually all types of care environments covering other interrelated areas of care: Hygiene Systems, Patient Lifters, Disinfection, Therapeutic Support Surfaces, Acute Care Medical Beds, and Wound Healing.

For more information about what ArjoHuntleigh can offer, please visit or contact ArjoHuntleigh at

Additional information:

DVT is a blood clot that develops in the calf, thigh or arm. If a fragment of the blood clot breaks off and moves to the lungs it is called a Pulmonary Embolism, and this is often fatal. The risk factors for DVT include: prolonged immobility, cancer, heart and respiratory disease, obesity and a previous DVT. These can increase someone's risk and the more multiple factors the greater the risk. People are more susceptible to DVT if they are over 40 and undergo surgery.

Safer Healthcare Now has 10 targeted interventions. They can be accessed through the website Safer Healthcare Now is a campaign of the Canadian Patient Safety Institute, a Federal body established in 2005 to reduce preventable deaths among Canadian patients.

ArjoHuntleigh with people in mind focuses on the needs of the patient or resident, caregiver and caregiver administration. ArjoHuntleigh was formed following the recent merger of ARJO and Huntleigh Healthcare. The original Huntleigh organization has almost 40 years of experience in manufacturing medical compression. ArjoHuntleigh has over 50 years experience in Canada with over 100 employees, which includes 35 in sales & marketing and 42 in field service. ArjoHuntleigh is a member of the Getinge AB Group who is a global provider of equipment and systems to customers within healthcare, extended care and pharmaceutical industries/laboratories. In 2007, the Getinge Group global sales exceeded CAD$2.7 billion dollars.

Medbuy is Canada's leading healthcare Group Purchasing Organization. Medbuy leverages the collective purchasing power of more than 350 healthcare facilities to deliver the best net price for healthcare supplies, pharmaceuticals and services, at the lowest cost. The Medbuy mission is to support their Member supply chain needs through innovative contracting and value-added services. And since their inception, they have returned more than $150 million in rebates in addition to providing one-of-a-kind programs that expand savings opportunities and enhance their Member knowledge base. Medbuy savings enable hospitals and healthcare organizations to reinvest dollars where it counts - into patient care.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Gregory